Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$593.6M
+22.0% from 2023
Prescriptions
41K
$14,330.18 per claim
Patients
7,012
5,438 prescribers
Total spending, 2024
$593.9M
$84,653.63 per patient
Medicare prescription drug plans paid $593.6M for Lynparza in 2024, for 41,421 prescriptions and refills to 7,012 patients (up 22.0% from 2023). The average cost per claim was $14,330.18.
California had the highest Medicare cost for Lynparza in 2024: $86.9M for 6,163 claims, followed by New York ($53.7M).
Vladimir Hugec, hematology-oncology in Maplewood, MN, had the highest Medicare cost for Lynparza in 2024: 143 claims costing $2.1M.
Lynparza is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Vladimir Hugec Maplewood, MN | Hematology-Oncology | 143 | 28 | $2.1M |
| Thomas J Rutherford Tampa, FL | Obstetrics & Gynecology | 99 | 13 | $1.4M |
| Veronica L Schimp |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 4,542 | 34,371 | 6,022 | $460.3M |
| 2023 | 4,707 | 34,410 | 5,957 | $486.7M |
| 2024 | 5,438 | 41,421 | 7,012 | $593.6M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Gynecological Oncology |
| 83 |
| Under 11 |
| $1.2M |
| Amanda M Gibson Colorado Springs, CO | Nurse Practitioner | 69 | Under 11 | $1.1M |
| Angela M Scaringe Indianapolis, IN | Nurse Practitioner | 76 | 17 | $1.1M |
| Daniel W Sonnenburg Indianapolis, IN | Medical Oncology | 84 | 19 | $1.0M |
| Rebecca S Semanoff Camden, NJ | Nurse Practitioner | 63 | Under 11 | $989K |
| Mihran Shirinian Glendale, CA | Hematology-Oncology | 68 | Under 11 | $961K |
| Jennifer Hernandez New Hyde Park, NY | Physician Assistant | 64 | 11 | $943K |
| Juliet E Wolford Kettering, OH | Obstetrics & Gynecology | 56 | Under 11 | $913K |
| Jennifer A Wagmiller Livingston, NJ | Hematology-Oncology | 62 | Under 11 | $853K |
| Boris Bagdasarian Glendale, CA | Hematology-Oncology | 70 | Under 11 | $853K |
| Shelly M Seward Orlando, FL | Obstetrics & Gynecology | 51 | Under 11 | $836K |
| Sukumar Ethirajan Overland Park, KS | Hematology | 50 | Under 11 | $820K |
| Thomas R Buroker Ankeny, IA | Medical Oncology | 50 | Under 11 | $803K |
| Martha S Diaz New Haven, CT | Physician Assistant | 45 | 12 | $793K |
| Paul R Sieber Lancaster, PA | Urology | 55 | Under 11 | $788K |
| Elizabeth Shieh Knoxville, TN | Nurse Practitioner | 55 | Under 11 | $776K |
| Thanasak Sueblinvong Honolulu, HI | Gynecological Oncology | 56 | Under 11 | $775K |
| Theresa H Shao New York, NY | Internal Medicine | 77 | Under 11 | $756K |
| Robert W Holloway Orlando, FL | Gynecological Oncology | 48 | 11 | $754K |
| Donna M McNamara Hackensack, NJ | Hematology-Oncology | 55 | Under 11 | $750K |
| Seth Cohen New York, NY | Medical Oncology | 45 | Under 11 | $732K |
| Alok Pant Baltimore, MD | Gynecological Oncology | 56 | Under 11 | $729K |
| Sara M Jordan La Jolla, CA | Gynecological Oncology | 60 | Under 11 | $719K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Astrazeneca AZN | 41,444 | $593.9M |